Literature DB >> 11781693

The angiotensin converting enzyme I/D polymorphism in Russian athletes.

I B Nazarov1, D R Woods, H E Montgomery, O V Shneider, V I Kazakov, N V Tomilin, V A Rogozkin.   

Abstract

The deletion (D) allele of the human ACE gene is associated with higher ACE activity than the insertion (I) allele. There is controversy as to whether the ACE genotype may be associated with elite athletic status; recent studies have identified no significant associations amongst those drawn from mixed sporting disciplines. However, such lack of association may reflect the mixed nature of such cohorts, given that an excess frequency of the I allele has been reported amongst elite endurance athletes, and an excess of the D allele amongst those engaged in more power-orientated sports. We examined this hypothesis by determining ACE I/D allele frequency amongst 217 Russian athletes (swimmers, skiers, triathletes and track-and-field participants) prospectively stratified by performance ('outstanding' or 'average'), and the duration of their event (SDA (<1 min), MDA (1 to 20 min), and LDA (>20 min): short, middle and long distance athletes respectively). ACE genotype and allele frequencies were compared to 449 controls. ACE genotype frequency amongst the whole cohort, or the outstanding athletes alone, was no different to that amongst sedentary controls. However, there was an excess of the D allele (frequency 0.72, P=0.001) amongst the outstanding SDA group, and an excess of the I allele (frequency 0.63, P=0.032) amongst the outstanding MDA group. These findings were replicated in the outstanding swimmers, with track and field SDA similarly demonstrating an excess of the D allele (P=0.01). There was no association found between the outstanding LDA and ACE genotype (P=0.27). These data not only confirm an excess of the D allele in elite SDA, and I allele in elite MDA, but also offer an explanation as to why any such association may be hard to detect amongst a heterogeneous cohort of mixed athletic ability and discipline.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11781693     DOI: 10.1038/sj.ejhg.5200711

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  51 in total

Review 1.  Movement systems as dynamical systems: the functional role of variability and its implications for sports medicine.

Authors:  Keith Davids; Paul Glazier; Duarte Araújo; Roger Bartlett
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Super athletes or gene cheats?

Authors:  P McCrory
Journal:  Br J Sports Med       Date:  2003-06       Impact factor: 13.800

Review 3.  A framework for understanding the training process leading to elite performance.

Authors:  David J Smith
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 4.  Genes and human elite athletic performance.

Authors:  Daniel G Macarthur; Kathryn N North
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

5.  Y chromosome haplogroups of elite Ethiopian endurance runners.

Authors:  Colin N Moran; Robert A Scott; Susan M Adams; Samantha J Warrington; Mark A Jobling; Richard H Wilson; William H Goodwin; Evelina Georgiades; Bezabhe Wolde; Yannis P Pitsiladis
Journal:  Hum Genet       Date:  2004-10-20       Impact factor: 4.132

6.  Association between ACE D allele and elite short distance swimming.

Authors:  Aldo Matos Costa; António José Silva; Nuno Domingos Garrido; Hugo Louro; Ricardo Jacó de Oliveira; Luiza Breitenfeld
Journal:  Eur J Appl Physiol       Date:  2009-05-21       Impact factor: 3.078

Review 7.  The genetics of sports injuries and athletic performance.

Authors:  Nicola Maffulli; Katia Margiotti; Umile Giuseppe Longo; Mattia Loppini; Vito Michele Fazio; Vincenzo Denaro
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

8.  Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes.

Authors:  Aldo Matos Costa; António José Silva; Nuno Garrido; Hugo Louro; Daniel Almeida Marinho; Mário Cardoso Marques; Luiza Breitenfeld
Journal:  J Sports Sci Med       Date:  2009-09-01       Impact factor: 2.988

Review 9.  Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia.

Authors:  G Onder; C Della Vedova; F Landi
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

10.  Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training.

Authors:  Martine A I Thomis; Wim Huygens; Sofie Heuninckx; Monique Chagnon; Hermine H M Maes; Albrecht L Claessens; Robert Vlietinck; Claude Bouchard; Gaston P Beunen
Journal:  Eur J Appl Physiol       Date:  2004-04-09       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.